Financial Statements

Apollo Endosurgery, Inc. (APEN)

$10

0.00 (0.00%)

Cash Flow Statement

All numbers are in thousands
Year XLSX
2022
XLSX
2021
XLSX
2020
XLSX
2019
XLSX
2018
Operating Cash Flow -31,262-14,454-20,812-25,622-23,119
Net Income -39,839-24,682-22,611-27,432-45,787
Depreciation & Amortization 2,9663,2323,7304,0609,292
Deferred income taxes --3,0941,310160-
Stock-based compensation 6,7836,3862,1141,4871,403
Change in working capital -6,938710-7,5125521,619
Other non-cash items 5,7662,9942,157-4,44910,354
Investing Cash Flow -2,7451,5611,3701,0387,119
Investments in PPE -2,745-1,456-630-980-2,881
Acquisitions -3,0002,0002,00010,000
Other Investing Activites -17-18-
Financing Cash Flow 34967,58225,61330,5069,695
Debt repayment --38,150--21,668-12,500
Common Stock Issuance 1,22669,78223,262-21,857
Other Financing Activites -87735,9502,35152,174338
Accounts receivables -5,589-2,3321,0791,852-162
Accounts payables 5,774----1,264
Inventory -6,437-1,740-1,5598723,004
Other working capital -6864,782-7,032-2,17241
Cash at beginning of period 91,81237,20030,92125,00731,418
Cash at end of period 58,01291,81237,20030,92125,007
Capital Expenditure -2,745-1,456-630-980-2,881
Effect of forex changes on cash -142-77108-8-106
Net cash flow / Change in cash -33,80054,6126,2795,914-6,411
Free Cash Flow -34,007-15,910-21,442-26,602-26,000

Apollo Endosurgery, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Apollo Endosurgery, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.